Skip to Main Content
Kiran Kumar, M.D.

Kiran Kumar, M.D.

Chief of Lymphoma and Pediatrics Radiation Oncology Services; Program Director, Medical Residency

Associate Professor

School
Medical School
Department
Radiation Oncology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Education
    Medical School
    University of Chicago Pritzker School of Medicine (2013)
    Internship
    Presence Resurrection Medical Center (2014), Transitional Year
    Residency
    Stanford University Medical Center (2018), Radiation Oncology
    Graduate School
    University of California - Berkeley (2018)
    Other Post Graduate Training
    University of California - Berkeley (2018)
  • Publications
    Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung Adenocarcinoma
    Chou KN, Park DJ, Hori YS, Persad AR, Chuang C, Emrish SC, Ustrzynski L, Tayag A, Kumar K, Usoz M, Mendoza M, Rahimy E, Pollom E, Soltys SG, Lai SW, Chang SD Clinical lung cancer 2024 Nov 25 e337-e347
    ACR–ARS Practice Parameter for the Performance of Total Body Irradiation
    Reilly M, Dandapani SV, Kumar KA, Constine L, Fogh SE, Roberts KB, Small W, Schechter NR American Journal of Clinical Oncology: Cancer Clinical Trials 2023 May 46 185-192
    Serious Illness Communication Training Among Radiation Oncology Residents
    Christensen M, Kumar KA, Wang WS, Dharmarajan KV, Chang Z, McStay CK, Barina A, Siropaides C Practical Radiation Oncology 2023 May 13 e220-e229
    Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go?
    Patel AM, West L, Atluri PS, Yi SF, Rizvi SM, Geethakumari PR, Awan FT, Chen W, Shah JL, Desai NB, Goff HW, Kumar KA Practical Radiation Oncology 2023 Mar 13 e192-e199
    Artificial Intelligence–Empowered Radiation Oncology Residency Education
    Kwon YS, Dohopolski M, Morgan H, Garant A, Sher D, Rahimi A, Sanford NN, Vo D, Albuquerque K, Kumar K, Timmerman R, Jiang SB Practical Radiation Oncology 2023 Jan 13 8-10
    A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma
    Alsuwaidan A, Koduru P, Fuda F, Manuel Jaso J, Chen M, Rosado F, Luu HS, Sweed N, Garcia R, Doucet M, Desai NB, Kumar KA, Awan FT, Ramakrishnan Geethakumari P, Chen W American journal of clinical pathology 2022 Sep 158 338-344
    Primary central nervous system lymphoma: A real-world comparison of therapy access and outcomes by hospital setting
    Patel AM, Ali O, Kainthla R, Rizvi SM, Awan FT, Patel T, Pan E, Maher E, Desai NB, Timmerman R, Kumar KA, Ramakrishnan Geethakumari P Neuro-Oncology Practice 2022 May 9 183-192
    T-Cell Lymphomas, Version 2.2022
    Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H JNCCN Journal of the National Comprehensive Cancer Network 2022 Mar 20 285-308
    Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes
    Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman R, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel PA, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds Jr. RR, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X Transplantation and Cellular Therapy 2022 Feb 28 113.e1-113.e8
    Fundamentals of radiation oncology for treatment of vertebral metastases
    Gottumukkala S, Srivastava U, Brocklehurst S, Mendel JT, Kumar K, Yu FF, Agarwal A, Shah BR, Vira S, Raj KM Radiographics 2021 Nov 41 2136-2156